Pliant Therapeutics Inc (PLRX)
11.88
-0.02
(-0.17%)
USD |
NASDAQ |
Apr 25, 16:00
11.89
+0.01
(+0.08%)
After-Hours: 20:00
Pliant Therapeutics Accounts Payable (Quarterly): 4.531M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.531M |
September 30, 2023 | 3.36M |
June 30, 2023 | 2.31M |
March 31, 2023 | 1.419M |
December 31, 2022 | 1.58M |
September 30, 2022 | 3.206M |
June 30, 2022 | 3.116M |
March 31, 2022 | 4.684M |
December 31, 2021 | 2.971M |
Date | Value |
---|---|
September 30, 2021 | 2.605M |
June 30, 2021 | 2.764M |
March 31, 2021 | 2.886M |
December 31, 2020 | 2.023M |
September 30, 2020 | 3.14M |
June 30, 2020 | 2.483M |
March 31, 2020 | 2.532M |
December 31, 2019 | 1.25M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.25M
Minimum
Dec 2019
4.684M
Maximum
Mar 2022
2.756M
Average
2.764M
Median
Jun 2021
Accounts Payable (Quarterly) Benchmarks
Masimo Corp | 251.50M |
Liquidia Corp | 1.396M |
Vor Biopharma Inc | 0.815M |
CEL-SCI Corp | 1.144M |
AIM ImmunoTech Inc | 6.443M |